HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and ...

Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various ...

Deloitte’s 2026 Healthcare Outlook shows that while more than two-thirds of U.S. healthcare leaders expect to outperform competitors, rising policy uncertainty is pushing greater focus on digital care ...

More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

About 28% of American adults say it’s difficult to afford their prescription drugs, and the U.S. spends more on drugs than any peer nation, according to KFF. So who is responsible? According to Merith ...

Noom, a digital health company for chronic disease prevention, will begin offering oral medications for weight loss through its Noom Med program, it announced Thursday. New York City-based Noom helps ...

We are only two weeks into 2025, and a small handful of healthcare AI companies have already announced funding rounds exceeding $100 million — signaling a strong start to what investors predicted ...

The FDA has approved a pill version of Novo Nordisk’s blockbuster drug Wegovy, giving the company the lead in the pharmaceutical industry pursuit of oral weight loss drugs while also providing ...

Virtual and hybrid therapy companies are expanding rapidly amid persistently high demand levels for mental health services. On Tuesday, mental health care provider SonderMind participated in this ...

CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...

New research suggests that health systems are struggling to effectively use AI to improve patient engagement. The study, released earlier this month, found that while investments in tools like ambient ...

CTI Biopharma has something many biotech companies aspire to achieve—revenue. Sales of its approved cancer drug are growing, but commercialization comes with costs as does development of the molecule ...